Also categorized in Business of Medicine:
Targeting the Type I Interferon Pathway to Treat Patients With Lupus
x hide permanently

University of Leeds: New Drug Shows Promise in Slowing Growth of Bowel Cancer

India Education Diary

Photo: Pixabay

A new drug has shown promise in slowing the regrowth of tumours among some bowel cancer patients, according to new findings from a major trial.

The results of the FOCUS4-C trial, run by researchers at the University of Leeds, UCL, Oxford and Cardiff universities, were presented on 18 September at the European Society of Medical Oncology and published in the Journal of Clinical Oncology.

The trial looked at whether a drug called adavosertib, taken in the form of a daily pill, could delay tumour regrowth among patients with an aggressive sub-type of inoperable bowel cancer who ...